Example: quiz answers

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

disease activity. Three or more consecutive, monthly injections may be needed. ... Systemic adverse events including non-ocular haemorrhages and arterial thromboembolic events have ... • Eylea should not be used in pregnancy unless the potential benefit outweighs the potential risk to the foetus (see section 4.6). ...

Tags:

  Disease, Pregnancy, In pregnancy, Thromboembolic

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Related search queries